Cargando…
Molecular Imaging and Theragnostics of Thyroid Cancers
SIMPLE SUMMARY: According to the American Cancer Society, approximately 53,000 new cases of thyroid cancer were diagnosed and more than 2200 people died from the disease in 2020. New developments in molecular imaging are significantly improving thyroid cancer diagnostics and therapy. Continuous rese...
Autores principales: | Giovanella, Luca, Deandreis, Desiree’, Vrachimis, Alexis, Campenni, Alfredo, Petranovic Ovcaricek, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909041/ https://www.ncbi.nlm.nih.gov/pubmed/35267580 http://dx.doi.org/10.3390/cancers14051272 |
Ejemplares similares
-
Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review
por: Luisa Garo, Maria, et al.
Publicado: (2023) -
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023) -
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review
por: Giovanella, Luca, et al.
Publicado: (2021) -
Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis
por: Giovanella, Luca, et al.
Publicado: (2023) -
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
por: Giovanella, Luca, et al.
Publicado: (2023)